Copaxone and Restoril drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Copaxone (glatiramer acetate) and Restoril (temazepam). Common drug interactions include chest pain among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Copaxone and Restoril. It is created by eHealthMe based on reports of 57 people who take the same drugs from the FDA, and is updated regularly.

What is Copaxone?

Copaxone has active ingredients of glatiramer acetate. It is often used in multiple sclerosis. eHealthMe is studying from 56,931 Copaxone users. Check the latest studies of Copaxone.

What is Restoril?

Restoril has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 13,522 Restoril users. Check the latest studies of Restoril.

On Jul, 31, 2026

57 people who take Copaxone and Restoril together, and have interactions are studied.

Copaxone and Restoril drug interactions.

What are the common drug interactions of Copaxone and Restoril, by gender? *:

female:

Chest pain
Depression
Hypertension (high blood pressure)
Nausea (feeling of having an urge to vomit)
Abdominal pain upper
Balance disorder
Blindness
Gait disturbance
Headache (pain in head)
Myalgia (muscle pain)

male:

Dyspnoea (difficult or laboured respiration)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Actinic keratosis (skin disease due to sun exposure)
Activities of daily living impaired
Aggression
Amyotrophic lateral sclerosis (nervous system disease that attacks nerve cells called neurons in your brain and spinal cord)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Arrhythmia (irregular heartbeat)
Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)

What are the common drug interactions of Copaxone and Restoril, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Seizure (abnormal excessive or synchronous neuronal activity in the brain)

10-19:

n/a

20-29:

Arthralgia (joint pain)
Chest discomfort
Injection site reaction
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
Dizziness
Drug ineffective
Dysphagia (a condition in which swallowing is difficult or painful)
Flushing (the warm, red condition of human skin)
Injection site pain

30-39:

Anxiety
Asthenia (weakness)
Ataxia (loss of full control of bodily movements)
Pain
Aphasia (damage to the parts of the brain that control language)
Back pain
Blood chloride increased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Carbon dioxide decreased
Chest pain

40-49:

Back pain
Dyspnoea (difficult or laboured respiration)
Nausea (feeling of having an urge to vomit)
Abdominal pain
Cough
Fatigue (feeling of tiredness)
Malaise (a feeling of general discomfort or uneasiness)
Muscle stiffness
Myalgia (muscle pain)
Neurogenic bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion)

50-59:

Cerebral haematoma (collection of blood in brain)
Cerebral haemorrhage (bleeding within the brain)
Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
Confusional state
Cranial nerve paralysis (loss of function of cranial nerve)
Depression
Device dislocation
Diplopia (double vision)
Eye pain

60+:

Balance disorder
Gait disturbance
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Haemoglobin decreased
Nasopharyngitis (inflammation of the nasopharynx)
Anxiety
Bowel movement irregularity
Cataract (clouding of the lens inside the eye)
Chest pain

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 3 people, 5.26%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 3 people, 5.26%
Hypersensitivity: 3 people, 5.26%
High Blood Pressure: 3 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Copaxone and Restoril?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously